Related by context. All words. (Click for frequent words.) 72 therapeutics 68 oncology therapeutics 66 antibody therapeutics 65 anticancer agents 65 immunotherapeutics 65 small molecule 65 therapeutic antibodies 65 monoclonal antibodies 63 stem cell therapeutics 63 novel peptides 63 kinase inhibitors 63 small molecule inhibitors 62 small molecule therapeutics 62 protein therapeutics 62 therapeutic monoclonal antibodies 62 proteasome inhibitors 62 microRNA therapeutics 62 RNAi therapeutics 61 anticancer therapeutics 61 Nanobody 61 oncolytic viruses 61 therapies 61 biotherapeutics 61 IAP inhibitors 61 novel therapeutics 61 anticancer drugs 61 immunologic diseases 61 immunotherapies 61 anticancer therapies 60 cancer immunotherapy 60 biomarker discovery 60 antiviral therapeutics 60 chemotherapeutics 60 monoclonal antibody 60 novel peptide 60 Cylene 60 therapeutic monoclonal antibody 60 siRNA delivery 59 PARP inhibitors 59 humanized monoclonal antibodies 59 Curaxin 59 cancer immunotherapies 59 histone deacetylase inhibitors 59 biotherapeutic 59 disease modifying 59 siRNA therapeutics 59 molecular biomarkers 59 antisense drugs 59 BCR ABL inhibitors 59 isoform selective 59 Tarvacin TM 59 Nasdaq HALO biopharmaceutical 59 NASDAQ CYTR biopharmaceutical 59 vascular disrupting agent 59 therapeutic antibody 59 M2 subunit 59 selective inhibitors 59 compound COTI 59 Tranzyme 58 histone methyltransferases HMTs 58 epothilones 58 protein biomarkers 58 rxRNA 58 RNAi therapeutic 58 HDAC inhibitors 58 anticancer compounds 58 immunotherapeutic 58 histone deacetylase HDAC inhibitors 58 molecular imaging radiopharmaceuticals 58 investigational pan BCR 58 biopharmaceutical 58 epothilone 58 monoclonal antibody therapeutics 58 Vegenics 58 Stapled Peptide 58 small molecule modulators 58 JAK1 58 Inc. NASDAQ CRIS 58 molecularly targeted 58 CBLC# 58 PI3K inhibitor 58 preclinical compounds 58 NASDAQ ALTH biopharmaceutical 58 PI3K/mTOR 58 delta isoform 58 tiapamil 58 Nanobody ® 58 Algeta ASA OSE ALGETA 58 biomarkers 57 anti mitotic 57 LNP formulations 57 Nasdaq MITI biopharmaceutical 57 vascular disrupting agents 57 ophthalmic therapeutics 57 DOS# 57 biologic therapies 57 KineMed 57 LNPs 57 humanized monoclonal antibody 57 VitiGam 57 Semafore 57 investigational monoclonal antibody 57 biologic therapeutics 57 CD# antibody [001] 57 oncology 57 siRNA compounds 57 MEK inhibitors 57 novel antibody therapeutics 57 nanomedicines 57 RNA antagonists 57 engineered proteases 57 humanized antibody 57 monoclonal antibody mAb 57 immunological diseases 57 G Protein Coupled 57 inhibits Akt activation 57 human antibody therapeutics 57 adrenal steroid hormones 57 preclinical 57 tyrosine kinase inhibitor 57 RNA interference RNAi therapeutics 56 3 kinase PI3K 56 Intellikine 56 telomerase therapeutic 56 selective androgen receptor modulators 56 PI3K inhibitors 56 protein kinase inhibitors 56 AEG# 56 PI3 kinase inhibitors 56 antibody fragment therapeutics 56 aTyr Pharma 56 RNAi 56 diagnostic biomarkers 56 molecular imaging 56 TLR Therapeutics 56 TLR9 agonists 56 aptamer therapeutics 56 novel immunotherapies 56 Anticalins R 56 Nasdaq PARD biopharmaceutical 56 Adnectin 56 Ambrx 56 SARMs 56 novel RNAi therapeutics 56 Cancer Therapeutics 56 VEGF receptor 56 antiviral compounds 56 ArQule Kinase Inhibitor Platform 56 humanized anti 56 ALN TTR 56 ALN PCS 56 taxane derivative 56 oncolytic 56 dermatology therapies 56 vaccines oncolytic virus 56 Hsp# inhibitor 56 cyclin dependent kinases 56 aptamers 56 Acetylon 56 Tumour Vascular Disrupting Agent 56 selective inhibition 56 investigational humanized monoclonal antibody 56 Nasdaq IMGN biotechnology 56 biased ligands 56 antisense drug 56 MAbs 56 siRNA therapeutic 56 proteasome inhibitor 56 systemic RNA interference 56 renin inhibitors 56 IAP inhibitor 56 angiogenesis inhibitor 56 biomarker 56 Fibroblast Growth Factor Receptor 56 anticancer agent 56 NASDAQ OPXA 56 Hsp# inhibition 56 XmAb ® 55 novel antiviral therapeutics 55 Plexxikon 55 PRNewswire FirstCall Nastech Pharmaceutical 55 Nasdaq ENZN 55 predictive biomarkers 55 small molecule inhibitor 55 small molecule agonists 55 RNAi therapeutic targeting 55 Phylogica 55 A3 adenosine receptor 55 Stemgent 55 therapeutic proteins 55 anticoagulant reversing agent 55 epigenetic enzymes 55 oxidative stress inducer 55 investigational therapies 55 Onalta 55 liposome formulations 55 SR Pharma 55 CAMBRIDGE Mass. Alnylam Pharmaceuticals 55 CCR9 antagonist 55 Nasdaq CYTR biopharmaceutical 55 Provectus Pharmaceuticals specializes 55 HGS# 55 Omacetaxine 55 tubulin inhibitor 55 Hsp# inhibitors 55 anti infective treatments 55 Exelixis compounds 55 NeurAxon Inc. 55 Kolltan Pharmaceuticals 55 Adenosine Therapeutics 55 Hybridon 55 Adherex Technologies 55 triggers apoptosis programmed 55 molecular diagnostic tests 55 myelofibrosis polycythemia vera 55 Corp. OTCBB ADVR 55 novel anti infective 55 Symphogen 55 HSP# inhibitor 55 Receptos 55 FOLOTYN ® 55 Debio 55 Inc. Nasdaq INFI 55 Gemin X 55 ophthalmic diseases 55 immune modulation 55 Dicer Substrate Technology 55 immunotherapy 55 antisense inhibitors 55 SCYNEXIS 55 histone deacetylase HDAC 55 fusion proteins 55 HepDirect R 55 AMPK activators 55 bluebird bio 55 AKIP ™ 55 Dicerna 55 PI3K delta 55 Protein Kinase C 55 Vaccinex 55 targeted radiotherapeutic 55 Mersana Therapeutics 55 Adnectins 55 antisense 55 mitogen activated ERK kinase 55 bioactive lipids 55 OMP #M# 55 rxRNA compounds 55 Curaxins 55 Phylomer ® 55 nitric oxide donating 55 deacetylase inhibitors 55 inflammatory diseases 55 SGLT Inhibitors 55 protein kinase inhibitor 55 FGFR 55 sirtuin therapeutics 55 enhance ApoA 55 NovaBay Aganocide compounds 55 humanised monoclonal antibody 55 ALN VSP 55 MDRNA proprietary 55 Azedra 55 histone deacetylase HDAC inhibitor 55 molecular chaperone 55 novel therapeutic antibodies 55 human monoclonal antibody 55 Atiprimod 55 theranostic 55 microRNA 55 biomarker identification 55 CNS therapeutics 54 Agios Pharmaceuticals 54 commercialize microRNA 54 antiangiogenesis therapies 54 Proxinium TM 54 oral antiviral 54 immunomodulators 54 proliferative diseases 54 PROfusion 54 metaglidasen 54 Celator 54 NYSE Amex RNN 54 AKT inhibitor 54 Chemokine 54 platinum chemotherapeutic 54 biased ligand 54 GeneICE 54 neurodegenerative diseases 54 anti infective 54 aptamer 54 ProNAi 54 MEK inhibitor RDEA# 54 AVEO Pharmaceuticals Inc. 54 Locked Nucleic Acid LNA 54 antibody MAb 54 lipid nanoparticles 54 dermatology biopharmaceutical 54 Stapled Peptides 54 NuMimetic TM 54 CYT# potent vascular disrupting 54 Lycera 54 TAFA# 54 monoclonal antibodies MAbs 54 Affitech AS 54 TRAIL receptor 54 NASDAQ LGND 54 siRNA 54 Fleximer 54 theranostics 54 transfection reagents 54 Monoclonal antibodies 54 CEQ# 54 kinase inhibitor 54 IIB ActRIIB 54 anticancer compound 54 kinase inhibition 54 humanized antibodies 54 anti angiogenic drugs 54 Tarvacin 54 RONDEL ™ 54 optimized siRNA 54 immunotoxin 54 antibody 54 CNS disorders 54 polymerase inhibitors 54 Applied NeuroSolutions 54 GPCR targets 54 endocrine therapy 54 TÎ ² 4 54 OTCBB PYTO FWB ET6 54 New Chemical Entities 54 Novosom 54 PRNewswire FirstCall YM BioSciences 54 miRNA therapeutics 54 TLR8 54 immune modulating 54 radiation sensitizer 54 commercializing anti infective 54 TRV# [001] 54 antisense oligonucleotides 54 Locked Nucleic Acid 54 Neuradiab 54 Transave 54 Preclinical studies suggest 54 humanized monoclonal 54 oral Azacitidine 54 Regado 54 obatoclax 54 Syndax 54 belinostat 54 Smac mimetics 54 HDAC inhibition 54 drug conjugate 54 DNAi 54 delivered RNAi therapeutic 54 targeting CD# 54 NASDAQ AEZS TSX AEZ 54 EGFr 54 Nasdaq MBRX announced 54 JAK3 54 AQ4N 54 Affibody 54 regenerative medicine 54 selective kinase inhibitor 54 Inc. AMEX YMI 54 NASDAQ SNTA biopharmaceutical 54 Galenea 54 MEK inhibitor 54 engineered RAP peptides 54 TLR9 agonist 54 antiviral therapies 54 mda 7 53 Panzem 53 Factor VIIa 53 MLN# 53 Cyclooxygenase Inhibiting Nitric Oxide 53 Anaphore 53 BiTE antibody 53 OncoVEX 53 HDACs 53 immunotherapeutic approaches 53 hedgehog pathway 53 chemical entities NCEs 53 Chemokine Therapeutics 53 NASDAQ ABII 53 therapeutic peptide 53 immunotherapeutic agent 53 novel anticancer 53 HGS ETR1 53 NCEs 53 orally bioavailable 53 Nexavar ® 53 catalytic antioxidant compounds 53 selective HDAC inhibitors 53 Solazed TM 53 BCR ABL 53 phosphate S1P 53 prostone 53 DXL# 53 chemotherapeutic agent 53 antibody therapies 53 Aeolus Pharmaceuticals 53 monoclonal antibody MAb 53 Pathway Inhibitor 53 elesclomol 53 Viventia 53 therapeutic 53 potently inhibit 53 immune modulatory 53 HuLuc# 53 FoldRx 53 targeted antifolate 53 SGLT inhibitors 53 synthetic peptide 53 insulin sensitizer 53 OGeS 53 TSX YM AIM 53 sodium glucose cotransporter 53 depsipeptide 53 coupled receptor GPCR 53 cilengitide 53 Archexin 53 Sphingomab 53 GAP #B# 53 biopharmaceuticals 53 JAK2 inhibitor 53 epigenetic therapeutics 53 Epizyme 53 Avila Therapeutics 53 Chrysalin 53 KinomeScan 53 systemic RNAi 53 peptide therapeutics 53 histone deacetylase 53 Tß4 53 Amira Pharmaceuticals 53 prodrugs 53 DsiRNA 53 rxRNA TM compounds 53 multi kinase inhibitor 53 HepDirect 53 XmAb 53 druggable targets 53 oral ghrelin agonist 53 Nanobodies ® 53 hematologic malignancies 53 Pertuzumab 53 oncolytic vaccine 53 Inc. Nasdaq PPHM 53 Nasdaq VRTX 53 genetic biomarkers 53 drug GAP #B# 53 Alternext ALEHT 53 ImmunoCellular Therapeutics Ltd. 53 TransMolecular 53 CDK inhibitors 53 romazarit 53 CD# antibodies 53 lipid mediators 53 PORxin TM 53 HER2 antibody 53 pertuzumab 53 AP# [003] 53 PNP inhibitor 53 UsiRNAs 53 Aegera Therapeutics 53 anticancer therapy 53 antimitotic 53 allosteric modulation 53 multitargeted 53 antagomirs 53 IgG1 monoclonal antibody 53 prolyl hydroxylase inhibitors 53 Nasdaq RDEA 53 fusion inhibitors 53 LentiVector technology 53 P#X# 53 receptor modulators 53 telomerase inhibitor drug 53 Tumor Necrosis Factor 53 Hedgehog signaling pathway 53 Cellzome 53 Trophos 53 JAK kinases 53 commercializing aptamer therapeutics 53 chemotherapeutic agents 53 Anchor Therapeutics 53 PARP inhibitor 53 IMC #B 53 ribonucleotide reductase clinically validated 53 dermatology biopharmaceutical company 53 PsychoGenics 53 XL# XL# 53 tests miRview TM 53 receptor monoclonal antibody 53 targeted anticancer therapeutics 53 dAbs 53 NEUGENE R 53 preclinically 53 anti angiogenesis 53 AMEX REX 53 Mesoblast Limited ASX MSB 53 Sym# 53 antibiotic anti infective 53 Resolvyx 53 GPR# agonist 53 therapeutic peptides 53 monoclonal antibody therapies 53 Inc. NASDAQ ALTH 53 Neurogen Corporation 53 TSX VENTURE GAP 53 PI3 kinase 53 chemically modified siRNA 53 BioSeek 53 peptide conjugated 53 cellular immunotherapy 53 GRN#L 53 intracellular signaling pathways 53 monoclonal 53 Piramed 53 gene silencing 53 Fc fusion protein 53 hypoxia inducible factor 53 Hedgehog pathway 53 OTCBB PYTO 53 oral JAK#/JAK# inhibitor 53 RNAi molecules 53 Oracea TM 53 inhibiting tumor 53 Cyclosert TM 53 oral prodrug 53 ProLindac TM 53 tyrosine kinase inhibitors 53 peptide peptide mimetic 53 induce apoptosis 53 huC# DM4 53 Angiocept 53 RNA interference RNAi 53 kidney urologic 53 Nasdaq IDRA 53 CD# expressing 53 anti angiogenic 53 OTCBB OHRP 53 OvaRex R 53 Tarmogen 53 OTCBB NVLT biopharmaceutical 53 CR# vcMMAE 53 NIC5 52 Alfacell proprietary ribonuclease 52 RXi 52 Homspera TM 52 Mirna Therapeutics 52 liposomal 52 Curaxin CBLC# 52 EGFR HER 52 c Raf kinase 52 OTCBB HXBM developer 52 Inc. NASDAQ AEZS 52 antisense therapeutics 52 NASDAQ PANC biotechnology 52 ARYx Therapeutics 52 oncolytic virus 52 Seliciclib 52 NASDAQ BTRX pharmaceutical 52 Receptors GPCRs 52 Response Genetics Inc. 52 ImmunoGen Inc. 52 TRC# 52 Inc. OTCBB LPTN 52 VentiRx 52 novel immunotherapeutic 52 perifosine novel potentially 52 Jennerex 52 Nasdaq LXRX biopharmaceutical 52 BAY #-# 52 Scancell 52 molecular diagnostics 52 Naurex 52 apoptotic pathway 52 HepaLife 52 Taligen 52 organ transplant rejection 52 siRNA molecules 52 FoldRx Pharmaceuticals Inc. 52 mAbs 52 IGF 1R 52 EGFR pathway 52 Combivir Kivexa 52 metabolic diseases 52 Nanobodies 52 Aurora kinase 52 NYSE Amex NBY clinical 52 ALN TTR# 52 rALLy clinical trial 52 Annamycin 52 PSN# [002] 52 imaging radiopharmaceuticals 52 cellular pathways 52 inhibit viral replication 52 Velcura 52 HuCNS SC ® 52 FibroGen 52 Aptamer 52 commercializing therapeutic 52 InNexus 52 Calistoga Pharmaceuticals 52 diagnostic assays 52 Allovectin 7 52 EOquin 52 anticancer treatments 52 liposomal delivery 52 siRNA sequences 52 protein tyrosine phosphatase 1B 52 polyclonal antibodies 52 OncoVEX GM CSF 52 investigational hepatitis C 52 PanGenetics 52 ProtAffin 52 commercializing novel 52 RenaZorb TM 52 J. Mazzo Ph.D. 52 XmAb TM 52 microRNAs 52 PLX# 52 PORxin 52 GRNVAC1 52 Ascenta Therapeutics 52 immune modulators 52 protein mTOR 52 HDAC inhibitor 52 Onco TCS 52 Aurora kinase inhibitor 52 Genetronics 52 peptibody 52 receptor tyrosine kinase inhibitor 52 Angiochem 52 Phenoxodiol 52 Tekmira Pharmaceuticals Corporation 52 Selective Electrochemical Tumor Ablation 52 bio therapeutics 52 Opexa 52 Anticalin R 52 ANAVEX 52 derivatives Radilex TM 52 ImmunoGen 52 IMC A# 52 Enhanze TM Technology 52 Nasdaq OMER 52 mAb 52 preclinical studies 52 Nanobodies ® novel 52 treat refractory angina 52 molecular imaging radiopharmaceutical 52 Serenex 52 BN# [002] 52 Perifosine 52 vinca alkaloid 52 Amrubicin 52 DiLA2 52 zanolimumab 52 RGB # 52 telomerase inhibitor 52 Biomerk Tumorgrafts 52 Alocrest 52 YM AIM YMBA 52 Nanobodies R 52 Robert L. Bratzler 52 dasatinib Sprycel 52 targeting PCSK9 52 mitotic kinesins 52 secretory phospholipase A2 52 tumor antigens 52 Squalamine 52 immuno inflammatory diseases 52 selective inhibitor 52 selective orally bioavailable 52 Pervasis 52 epigenetic therapies 52 VisEn Medical 52 phenoxodiol 52 specific lectin receptors 52 OTC BB PVCT 52 phosphoinositide 3 52 PSD Xetra PSI 52 PLK1 SNALP 52 anti phosphatidylserine 52 oral proteasome inhibitor 52 LungExpress Dx TM 52 commercialize microRNA therapeutics 52 Tranzyme Pharma 52 Cobalamin TM mediated 52 alpha antagonist 52 carbohydrate compounds 52 microtubule inhibitor 52 NYSE Amex PBTH 52 small molecule glucokinase 52 neuronal nicotinic receptors NNRs 52 Ep CAM 52 FluoroPharma 52 oral kinase inhibitor 52 Mersana 52 Antigen Express 52 PROT biotechnology 52 Elixir Pharmaceuticals 52 MVA BN R 52 chemotherapeutic drugs 52 PDE4 inhibitor 52 JAK inhibitors 52 Panzem R NCD 52 ADI PEG 52 nab docetaxel 52 trastuzumab DM1 T DM1 52 adrenergic regulation 52 thymidylate synthase TS 52 Nasdaq CGEN 52 GRN# 52 Epothilones 52 selectively induce apoptosis 52 Daclizumab 52 Radiation Therapy SIRT 52 tubulin inhibitors 52 allosteric modulator 52 CD# monoclonal antibody 52 bevacizumab Avastin ® 52 NTDDS 52 HCV polymerase inhibitors 52 AVEO 52 IDM Pharma 52 Fleximer R 52 GED aPC 52 2 inhibitor CYT# 52 Elesclomol 52 anti CD# antibody 52 ALTROPANE R 52 pan HDAC inhibitor 52 nanomedicine 52 galectin 52 Nasdaq ASTM 52 vaccine GRNVAC1 52 fibrotic diseases 52 HSP# inhibitors 52 Nasdaq IDIX biopharmaceutical 52 compound perifosine 52 highly selective endothelin 52 Onconase 52 Adnexus Therapeutics 52 molecular diagnostic 52 exon skipping 52 NASDAQ PPHM clinical 52 anti CD# antibodies 52 GLOBE NEWSWIRE Achillion Pharmaceuticals 52 kinase profiling 52 EGF receptor 52 Dr. Aiping Young 52 Orexo 52 bioengineered vaccines 52 BiTE R 52 TSX TKM 52 NASDAQ INGN 52 Cotara R 52 Nasdaq PANC biotechnology 52 CLAVIS 52 anti CD3 52 Nasdaq RGDX 52 Panzem R 52 Gleevec resistant 52 PI3K/Akt pathway inhibitor 52 generation proteasome inhibitor 52 DECIPHER R 52 androgen receptor antagonist 52 OSI Prosidion 52 Akebia Therapeutics 52 Board LWLG technology 52 novel immunomodulatory 52 Syrrx 52 Viprovex TM 52 CD3 monoclonal antibody 52 HTS assay 52 Wadih Arap 52 TKB# 52 allogeneic cell 52 Myolimus 52 ESBA# 52 histone deacetylase inhibitor 52 Survivin antagonist 52 CYC# 52 including Cobalamin TM 52 co stimulatory molecules 52 antisense oligonucleotide 52 Intradigm Corporation 52 VEGF inhibitors 52 small molecule tyrosine 52 lipid nanoparticle 51 RAS MAPK pathway 51 Fx #A 51 Metaphore 51 Litx 51 Pentad TM 51 HIV integrase inhibitors 51 OvaRex ® MAb 51 AtuRNAi 51 bispecific antibodies 51 ABL inhibitor 51 mRNA antagonists 51 Ablaris Therapeutics 51 PRNewswire FirstCall Neurogen 51 ApoB SNALP 51 siRNAs targeting 51 oxazolidinone 51 diagnostic biomarker 51 antibody fragment 51 mTOR inhibitors 51 Ophthotech 51 Sudhir Agrawal D.Phil 51 alpha folate receptor 51 anti CD3 monoclonal 51 p# inhibitor 51 Corixa Corporation 51 PluriCells TM 51 novel peptide therapeutics 51 HCV protease inhibitors 51 Nasdaq RXII 51 Spiro Rombotis President 51 AvalonRx R 51 Aileron Therapeutics 51 accumulate preferentially 51 Æterna Zentaris Inc. 51 Aganocide ® 51 MCSP respectively 51 TKIs 51 chimeric monoclonal antibody 51 selectively inhibit 51 candidate CRLX# 51 ENMD # 51 lentiviral vectors 51 IMiDs R 51 resolvins 51 IRX 2 51 TOPIGEN 51 somatostatin analogue 51 ImmuneRegen BioSciences Inc. 51 Affibody ® molecules 51 NasdaqCM PSTI DAX PJT 51 tkRNAi 51 NP2 Enkephalin 51 IMA# 51 Inc. Nasdaq TNGN 51 Achaogen 51 HGS ETR1 mapatumumab 51 Heptares 51 immunotherapy treatments 51 Tetraphase Pharmaceuticals 51 maytansinoid 51 Cellerant 51 ErbB3 HER3 51 virotherapy 51 markets biosurgical 51 anionic backbone 51 Etubics 51 Azedra TM 51 OTCBB NRGX biotechnology 51 BHT DNA 51 recombinant antibodies 51 ADVEXIN p# therapy 51 anti infective therapeutics 51 pharmacogenetic test 51 vivo fluorescence imaging 51 Symadex 51 vinca alkaloids 51 specialty biopharmaceutical 51 liposomal formulation 51 Ceflatonin R 51 short interfering RNA 51 mertansine 51 AMEX RGN 51 CD# CEA 51 MMAE 51 Sapacitabine 51 entinostat 51 MDV# 51 hepatitis C virus HCV 51 GenSpera 51 Epidermal Growth Factor Receptor 51 ospemifene 51 sodium thiosulfate STS 51 antitumor 51 activate SIRT1 51 tumor antigen 51 Romidepsin 51 stable nucleic acid 51 chemotherapeutic 51 factor receptor FGFR 51 metastatic colorectal 51 GENFIT 51 candidate deforolimus 51 Onconova 51 candidate voreloxin 51 nicotinic alpha 7 51 OXi# 51 Mipomersen 51 OTCBB IMUC 51 PharmaFrontiers 51 chemokine receptors 51 anti infective compounds 51 XmAb ™ 51 EpCAM 51 HQK 51 generation antisense 51 Cytopia 51 Quinamed 51 chronic viral infections 51 RNA therapeutics 51 camptothecin 51 proprietary Dicer Substrate Technology 51 methionine aminopeptidase 51 glycobiology 51 agonistic human 51 CTLA4 Ig 51 DPX Survivac 51 dasatinib Sprycel ® 51 TetraLogic Pharmaceuticals 51 Astex Therapeutics 51 IL# PE#QQR 51 Inc. Nasdaq IMGN 51 Personalized Immunotherapy 51 ANG# 51 antisense inhibitor 51 hormone gastrin 51 TARIS 51 prophylactic vaccine 51 Stem Cell Innovations 51 Tesetaxel 51 Guanilib 51 omacetaxine 51 AnaptysBio 51 Regado Biosciences 51 FLT3 51 Epitomics 51 JAK inhibitor 51 HER1 51 AAG geldanamycin analog 51 MCU cardiovascular 51 Affimed Therapeutics AG 51 marketed EGFR 51 microRNA miRNA 51 telomerase activators 51 Inc. Nasdaq ACHN 51 novel orally administered 51 induces apoptosis 51 oral taxane 51 oral Janus kinase 51 Carigent 51 Epratuzumab 51 RONDEL TM 51 HuCAL antibody 51 anticancer 51 Taxanes 51 proteomics 51 PLX MS 51 mGluR4 51 encapsulates siRNAs 51 pharmacological chaperone 51 ATL/TV# 51 PDGF receptor 51 Opexa Therapeutics Inc. 51 TELCYTA TM TLK# 51 antitumoral 51 commercializing novel biotherapeutics 51 ARRY # 51 immune stimulatory 51 HDAC 51 NASDAQ FLML 51 BGC# 51 Inc. Nasdaq NLTX 51 iCeutica 51 Epeius Biotechnologies Corporation 51 ocular diseases 51 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 51 drug zotarolimus 51 Hana Biosciences 51 Metallophile ™ Technology 51 SCIB1 51 SOD1 51 Archemix Corp. 51 diagnostic molecular imaging 51 Inc. NASDAQ CLDA 51 GPR# agonists 51 Nasdaq HALO 51 #/#/# Cytokinetics Incorporated 51 immunoregulatory 51 clinically validated targets 51 Bavituximab 51 synthetic cannabinoid compounds 51 biochemical profiling 51 topical anti infective 51 Zalypsis 51 CTAP# Capsules 51 Trofex TM